US 11083737
Methods of administering deflazacort therapy
granted A61KA61K31/58A61K45/06
Quick answer
US patent 11083737 (Methods of administering deflazacort therapy) held by PTC THERAPEUTICS, INC. expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/58, A61K45/06, A61K47/02, A61K47/10